Synergistic effect of low‐frequency ultrasound and low‐dose bradykinin on increasing permeability of the blood–tumor barrier by opening tight junction

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neuroscience Research

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/jnr.22061PMID 19326437
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MRI-guided targeted blood-brain barrier disruption and drug delivery to rabbit brain with focused ultrasound

  2009cited by this paper
• Carrier-Mediated Transport of the Quaternary Ammonium Neuronal Nicotinic Receptor Antagonist N,N′-Dodecylbispicolinium Dibromide at the Blood-Brain Barrier

  2008cited by this paper
• Bradykinin increases blood–tumor barrier permeability by down‐regulating the expression levels of ZO‐1, occludin, and claudin‐5 and rearranging actin cytoskeleton

  2008influential reference
• cDNA cloning, characterization and expression analysis of the antioxidant enzyme gene, catalase, of Chinese shrimp Fenneropenaeus chinensis.

  2008cited by this paper
• Involvement of the low‐density lipoprotein receptor‐related protein in the transcytosis of the brain delivery vector Angiopep‐2

  2008cited by this paper
• Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat Model

  2008cited by this paper
• Ultrasound for drug and gene delivery to the brain.

  2008influential reference
• Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index.

  2008influential reference
• Low dose of bradykinin selectively increases intracellular calcium in glioma cells.

  2007cited by this paper
• Spatio-temporal analysis of molecular delivery through the blood–brain barrier using focused ultrasound

  2007influential reference
• Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway.

  2007cited by this paper
• Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel.

  2007cited by this paper
• Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling.

  2007cited by this paper
• Dexamethasone enhances adenosine 5'-triphosphate-sensitive potassium channel expression in the blood-brain tumor barrier in a rat brain tumor model.

  2007cited by this paper
• Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI‐guided focused ultrasound

  2007influential reference
• Multiphoton Imaging of Ultrasound/Optison Mediated Cerebrovascular Effects in vivo

  2007influential reference
• Enhanced Disruption of the Blood Brain Barrier by Intracarotid Mannitol Injection During Transient Cerebral Hypoperfusion in Rabbits

  2007cited by this paper
• Future developments in neurovascular ultrasound.

  2006influential reference
• MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits.

  2005cited by this paper
• Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications

  2005influential reference
• Isolation and Culture of Microvascular Endothelial Cells from Gliomas of Different WHO Grades

  2005cited by this paper
• Disruption of the cingulin gene does not prevent tight junction formation but alters gene expression

  2004cited by this paper
• Blood-brain barrier permeability and vascular reactivity to bradykinin after pretreatment with dexamethasone

  2004influential reference
• Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme

  2003cited by this paper
• Regulation of blood-brain tumor barrier permeability by calcium-activated potassium channels.

  2002influential reference
• Mechanisms regulating the expression, self‐maintenance, and signaling‐function of the bradykinin B2 and B1 receptors

  2002cited by this paper
• Tight junctions of the blood-brain barrier: development, composition and regulation.

  2002cited by this paper
• Overexpression of bradykinin type 2 receptors on glioma cells enhances bradykinin-mediated blood–brain tumor barrier permeability increase

  2002cited by this paper
• The Development of the Bradykinin Agonist Labradimil as a Means to Increase the Permeability of the Blood-Brain Barrier

  2001influential reference
• Molecular physiology and pathophysiology of tight junctions. IV. Regulation of tight junctions by extracellular stimuli: nutrients, cytokines, and immune cells.

  2000cited by this paper
• Tight Junctions of the Blood–Brain Barrier

  2000cited by this paper
• Molecular physiology and pathophysiology of tight junctions. I. Biogenesis of tight junctions and epithelial polarity.

  2000cited by this paper
• Permeability of the blood brain barrier by the bradykinin agonist, RMP-7: evidence for a sensitive, auto-regulated, receptor-mediated system.

  1996cited by this paper
• Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, RMP-7.

  1996influential reference
• Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows.

  1994influential reference
• Intracarotid infusion of RMP-7, a bradykinin analog: a method for selective drug delivery to brain tumors.

  1994cited by this paper
• Blood-brain barrier disruption in immature Fischer 344 rats.

  1984cited by this paper

• Synergistic mechanotherapy and sonopermeation guided by mathematical modeling for solid tumor treatment

  2025cites this paper
• Low-intensity ultrasound combined with arsenic trioxide induced apoptosis of glioma via EGFR/AKT/mTOR.

  2023cites this paper
• Current and Emerging Systems for Focused Ultrasound-Mediated Blood-Brain Barrier Opening.

  2023cites this paper
• Low-intensity ultrasound: A novel technique for adjuvant treatment of gliomas.

  2022cites this paper
• Remodelling and Treatment of the Blood-Brain Barrier in Glioma

  2021cites this paper
• The reversal of MRP1 expression induced by low-frequency and low-intensity ultrasound and curcumin mediated by VEGF in brain glioma

  2019cites this paper
• Evaluating the safety profile of focused ultrasound and microbubble-mediated treatments to increase blood-brain barrier permeability

  2019cites this paper
• The reversal of MRP1 expression induced by low-frequency and low-intensity ultrasound and curcumin mediated by VEGF in brain glioma

  2019cites this paper
• Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound

  2017cites this paper
• Strategies that Target Tight Junctions for Enhanced Drug Delivery.

  2016cites this paper
• Drug Delivery to the Brain by Focused Ultrasound and Microbubble Mediated Blood-brain Barrier Disruption: Vascular-level Investigation using Two-photon Fluorescent Microscopy

  2015cites this paper
• Effect of caveolin-1 on the expression of tight junction-associated proteins in rat glioma-derived microvascular endothelial cells.

  2015cites this paper
• Transient disruption of vascular barriers using focused ultrasound and microbubbles for targeted drug delivery in the brain

  2014cites this paper
• Fighting fire with fire: the revival of thermotherapy for gliomas.

  2014cites this paper
• Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system

  2014cites this paper
• Overcoming the blood-brain barrier for chemotherapy: limitations, challenges and rising problems.

  2014cites this paper
• Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis.

  2013cites this paper
• Integrative and Translational Physiology : Inflammation and Immunity in Organ System Physiology Angiotensin-converting enzyme and the tumor microenvironment : mechanisms beyond angiogenesis

  2013cites this paper
• Low Intensity Ultrasound Promotes the Sensitivity of Rat Brain Glioma to Doxorubicin by Down-Regulating the Expressions of P-Glucoprotein and Multidrug Resistance Protein 1 In Vitro and In Vivo

  2013cites this paper
• Low frequency and intensity ultrasound induces apoptosis of brain glioma in rats mediated by caspase-3, Bcl-2, and survivin.

  2012cites this paper
• Ultrasound enhanced drug delivery to the brain and central nervous system

  2012cites this paper
• Low-Frequency Ultrasound Irradiation Increases Blood–Tumor Barrier Permeability by Transcellular Pathway in a Rat Glioma Model

  2012cites this paper
• Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller.

  2012cites this paper
• Mechanism of Low-Frequency Ultrasound in Opening Blood–Tumor Barrier by Tight Junction

  2011cites this paper
• Bradykinin Promotes the Chemotactic Invasion of Primary Brain Tumors

  2011cites this paper
• Effects of combining low frequency ultrasound irradiation with papaverine on the permeability of the blood–tumor barrier

  2011cites this paper
• 14 Kinins: kallikreins and kinins in cancer

  2011cites this paper
• Increasing of Blood-tumor Barrier Permeability through Paracellular Pathway by Low-frequency Ultrasound Irradiation In Vitro

  2011cites this paper
• Exploiting ultrasound-mediated effects in delivering targeted, site-specific cancer therapy.

  2010cites this paper
• Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches.

  2010cites this paper
• Additive effect of low-frequency ultrasound and endothelial monocyte-activating polypeptide II on blood-tumor barrier in rats with brain glioma.

  2010cites this paper